MedTrace Logo

Exogenous Ketone Ester in Women with Polycystic Ovary Syndrome.

NCT05762822 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-11-04

No results posted yet for this study

Summary

Polycystic ovarian syndrome (PCOS) is characterized by elevated androgens such as testosterone. Clinical studies suggest that ketogenic diets lower the levels of androgens. The ketone 3-hydroxybutyrate (3-OHB) may play an important role in these effects and the main purpose of this study is to investigate whether a 3-OHB supplement acutely improves the hormonal and metabolic status in women with PCOS.

Conditions

  • PCOS

Interventions

DIETARY_SUPPLEMENT

water

60 ml water (added bitter taste)

DIETARY_SUPPLEMENT

3-OHB (KE4)

60 ml (30 g) of 3-OHB

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Nikolaj Rittig · University of Aarhus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-10
Primary Completion
2024-10-30
Completion
2024-10-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05762822 on ClinicalTrials.gov